BioCentury

7:00 AM GMT, Aug 22, 2011
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

Probuphine buprenorphine: Additional Phase III data

Additional data from a U.S. Phase III trial in 287 patients aged 18-60 with opioid dependence showed that 36% of patients treated with Probuphine had negative urine samples

Read the full 288 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.